Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more ➡
Download
Standard view
Full view
of .
Add note
Save to My Library
Sync to mobile
Look up keyword
Like this
19Activity
×
0 of .
Results for:
No results containing your search query
P. 1
DOTS-Plus Guidelines Nov 2009

DOTS-Plus Guidelines Nov 2009

Ratings: (0)|Views: 3,018|Likes:
New DOTS Plus guidelines
New DOTS Plus guidelines

More info:

Published by: Prabir Kumar Chatterjee on Jun 20, 2010
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See More
See less

05/19/2012

pdf

text

original

 
 
Revised National TuberculosisControl ProgrammeDOTS-Plus Guidelines
Central TB Division, Directorate General of Health Services,
Ministry of Health & Family Welfare, Nirman Bhavan, New Delhi – 110011
 
 
Revised National TuberculosisControl ProgrammeDOTS-Plus Guidelines
November 2009
Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, NirmanBhavan, New Delhi – 110011
Staff members at the Central Tuberculosis Division, Ministry of Health and Family Welfare, New Delhi, the Lala Ram Sarup Institute of Tuberculosis and Allied Diseases, New Delhi, the National Tuberculosis Institute, Bangalore, the Tuberculosis Research Centre, Chennai, and theWorld Health Organization, New Delhi, contributed to the development of the RNTCP DOTS-Plus guidelines
 
 
Table of contents Page
 
Introduction……………………………………………………………………………..11. Background……………………………………………………………………...22. Framework for effective control of multidrug-resistant TB………………….83. Government commitment and coordination……….…………..……………...114. Case finding and definitions…………………………………………………...155. Diagnosis and evaluations…………………………………………………..….21
6.
Laboratory aspects……………………………………………………………..267. Treatment of multidrug-resistant TB.…………….…………………………..408. Monitoring and management of adverse drug reactions……………………509. MDR-TB in special situations………………….………………….……….…5610. Treatment delivery and adherence…………………………………………...6611. Human resource development for DOTS-Plus under RNTCP……………..7212. Logistics of second-line anti-TB drugs…….…………………………………7613. Recording and reporting system ……………………………………………..80
 
Annexures
I.
 
RNTCP Request for culture and drug sensitivity testingII.
 
History of anti-tubercular drugsIII.
 
Referral for DST Register (held at the DTC)IV.
 
IRL Culture and DST Register V.
 
DOTS-Plus Referral for treatment formVI.
 
Follow-up schedule during Category IV treatmentVII.
 
Checklist for initial evaluation and treatment surveillanceVIII.
 
RNTCP DOTS-Plus treatment cardIX.
 
RNTCP DOTS-Plus Treatment Register X.
 
RNTCP CAT IV TB Identity CardXI.
 
RNTCP Quarterly report on Category IV case findingXII.
 
RNTCP DOTS-Plus six month interim reportXIII.
 
RNTCP DOTS-Plus 12 months culture conversion reportXIV.
 
RNTCP Quarterly report on the result of treatment of MDR-TB patients on Category IV treatmentregimens registered 31-33 months earlier XV.
 
Evaluation at completion of Category IV treatmentXVI.
 
Quarterly report on Cat IV drug logisticsXVII.
 
Roles of the various facilities under RNTCP DOTS-PlusXVIII.
 
Job responsibilities of various categories of staff under DOTS-PlusXIX.
 
Second Line anti-TB drugs information sheets

Activity (19)

You've already reviewed this. Edit your review.
1 thousand reads
1 hundred reads
Rupika Dhurjati liked this
Ashok Patel liked this
Binu Sekhar liked this
Binu Sekhar liked this
Braylien Siy liked this
Braylien Siy liked this
Braylien Siy liked this

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->